HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Tadashi Matsuda Selected Research

Tyrosine Kinase 2 Deficiency

3/2020The mechanism of Tyk2 deficiency-induced immunosuppression in mice involves robust IL-10 production in macrophages.
5/2014Tyk2 is a therapeutic target for psoriasis-like skin inflammation.
9/2011Tyk2 deficiency protects joints against destruction in anti-type II collagen antibody-induced arthritis in mice.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Tadashi Matsuda Research Topics

Disease

37Neoplasms (Cancer)
01/2022 - 03/2002
23Prostatic Neoplasms (Prostate Cancer)
08/2021 - 02/2002
13Carcinoma (Carcinomatosis)
07/2022 - 01/2003
12Urinary Bladder Neoplasms (Bladder Cancer)
03/2021 - 03/2002
12Hemorrhage
09/2018 - 05/2002
11Inflammation (Inflammations)
07/2021 - 07/2011
9Neoplasm Metastasis (Metastasis)
01/2020 - 07/2003
8Breast Neoplasms (Breast Cancer)
01/2021 - 07/2002
6Prostatic Hyperplasia (Benign Prostatic Hyperplasia)
08/2021 - 01/2002
6Renal Cell Carcinoma (Grawitz Tumor)
03/2020 - 08/2012
6Hypogonadism (Hypergonadotropic Hypogonadism)
01/2018 - 09/2007
6Lower Urinary Tract Symptoms
11/2017 - 05/2015
6Infections
10/2017 - 11/2004
5Psoriasis (Pustulosis Palmaris et Plantaris)
01/2020 - 07/2011
5Pain (Aches)
01/2019 - 10/2010
4Urolithiasis
01/2021 - 09/2017
4Pheochromocytoma
12/2019 - 01/2009
4Lymphoma (Lymphomas)
07/2015 - 01/2006
4Hepatocellular Carcinoma (Hepatoma)
05/2015 - 01/2003
3Overactive Urinary Bladder (Overactive Bladder)
01/2022 - 08/2017
3Autoimmune Diseases (Autoimmune Disease)
01/2022 - 01/2017
3Urinary Tract Infections (Urinary Tract Infection)
11/2021 - 09/2006
3Carcinogenesis
01/2021 - 07/2015
3Tyrosine Kinase 2 Deficiency
03/2020 - 09/2011
3Paraganglioma (Paragangliomas)
12/2019 - 01/2009
3Arthritis (Polyarthritis)
01/2017 - 09/2011
3Urinary Retention
08/2016 - 04/2011
3Fever (Fevers)
02/2014 - 06/2005
3Leukemia
07/2008 - 07/2003
2Bites and Stings (Sting)
01/2022 - 01/2017
2Hyperplasia
12/2021 - 05/2014
2Adenocarcinoma
09/2021 - 09/2007
2Anaphylaxis (Anaphylactic Shock)
07/2021 - 04/2014
2Pyuria
11/2020 - 01/2020
2Wounds and Injuries (Trauma)
01/2020 - 01/2020
2Margins of Excision
01/2020 - 06/2012
2Urinary Calculi (Urinary Calculus)
01/2019 - 11/2017
2Testicular Neoplasms (Testicular Cancer)
09/2018 - 03/2018
2Urinary Incontinence
04/2018 - 01/2009

Drug/Important Bio-Agent (IBA)

13Proteins (Proteins, Gene)FDA Link
01/2022 - 07/2002
8CytokinesIBA
07/2021 - 11/2009
8AndrogensIBA
01/2019 - 01/2004
7Phosphotransferases (Kinase)IBA
01/2021 - 07/2003
7Interleukin-17 (Interleukin 17)IBA
01/2020 - 03/2012
7Messenger RNA (mRNA)IBA
01/2019 - 02/2002
5Prostate-Specific Antigen (Semenogelase)IBA
08/2021 - 09/2007
5Testosterone (Sustanon)FDA Link
01/2019 - 02/2009
5Granulocyte Colony-Stimulating Factor (G-CSF)IBA
12/2014 - 07/2005
3Dutasteride (Avodart)FDA Link
08/2021 - 09/2015
3Immunoglobulin E (IgE)IBA
07/2021 - 01/2004
3Hemoglobins (Hemoglobin)IBA
02/2019 - 04/2006
3Chorionic Gonadotropin (Human Chorionic Gonadotropin)FDA LinkGeneric
09/2018 - 01/2018
3Cisplatin (Platino)FDA LinkGeneric
09/2018 - 06/2013
3Collagen Type II (Type II Collagen)IBA
01/2017 - 09/2011
3LigandsIBA
01/2017 - 02/2007
3IntegrinsIBA
01/2017 - 10/2004
3DNA (Deoxyribonucleic Acid)IBA
01/2017 - 03/2002
3EndotoxinsIBA
12/2014 - 12/2007
3Small Interfering RNA (siRNA)IBA
05/2011 - 01/2006
3Interleukin-6 (Interleukin 6)IBA
07/2008 - 01/2003
29 alpha,11 alpha,15 alpha- trihydroxy- 16- phenoxy- 17,18,19,20- tetranorprosta- 4,5,13- trienoic acid (TPT)IBA
01/2022 - 01/2017
2Topotecan (Hycamtin)FDA LinkGeneric
01/2022 - 01/2017
2CateninsIBA
12/2021 - 05/2011
2Hematoxylin (Haematoxylon)IBA
09/2021 - 03/2021
2SynaptophysinIBA
09/2021 - 01/2010
2Eosine Yellowish-(YS) (Eosin)IBA
09/2021 - 03/2021
2Chromogranin AIBA
09/2021 - 01/2010
2Interleukin-4 (Interleukin 4)IBA
07/2021 - 01/2004
2AcidsIBA
06/2021 - 01/2020
2Uroplakin IIIBA
03/2021 - 07/2003
2Concanavalin AIBA
01/2021 - 01/2020
2STAT3 Transcription Factor (Signal Transducer and Activator of Transcription 3)IBA
01/2021 - 01/2003
2Interleukin-10 (Interleukin 10)IBA
01/2021 - 03/2020
2InterferonsIBA
01/2021 - 09/2013
2Analgesics (Analgesic Drugs)IBA
01/2020 - 07/2015
2alpha-Methyltyrosine (Metirosine)FDA Link
12/2019 - 03/2018
2CatecholaminesIBA
12/2019 - 03/2018
2Imiquimod (Aldara)FDA LinkGeneric
01/2019 - 07/2011
2Etoposide (VP 16)FDA LinkGeneric
09/2018 - 03/2018

Therapy/Procedure

24Therapeutics
07/2022 - 06/2005
14Prostatectomy (Retropubic Prostatectomy)
05/2020 - 04/2003
12Nephrectomy
11/2021 - 03/2002
10Cystectomy
03/2017 - 03/2002
6Stents
01/2022 - 11/2017
6Drug Therapy (Chemotherapy)
01/2022 - 06/2005
4Adrenalectomy
12/2021 - 01/2017
4Operative Time
11/2021 - 06/2012
3Nephroureterectomy
07/2022 - 03/2009
3Lasers (Laser)
06/2021 - 01/2016
3Lithotripsy (Extracorporeal Shockwave Lithotripsy)
01/2020 - 09/2017
3Castration
02/2019 - 09/2008
3Orchiectomy (Orchidectomy)
09/2018 - 12/2010
3Conservative Treatment
02/2018 - 03/2011
3Kidney Transplantation
10/2017 - 10/2015
3Catheters
11/2016 - 06/2005
2Laser Therapy (Surgery, Laser)
06/2021 - 01/2018
2Lymph Node Excision (Lymph Node Dissection)
01/2021 - 10/2019
2Urinary Catheters
01/2021 - 11/2011
2Transurethral Resection of Bladder
11/2020 - 03/2011
2Blood Transfusion (Blood Transfusions)
01/2020 - 02/2014